Following the unsolicited cash offer from Ramsay Génerale de Santé (Ramsay GDS) on July 13 of SEK 48.50 per share, unanimously rejected by the Board of Directors of Capio on the same day, Ramsay GDS has today announced an increased cash offer of SEK 58.00 per share (the “Increased Offer”) to the shareholders in Capio representing a premium of approximately 14% to the closing price of SEK 50.80 per share on Nasdaq Stockholm on October 5, 2018, and a premium of approximately 20% to the initial offer by Ramsay GDS of SEK 48.50 per share on July 13, 2018. The Board of Directors of Capio will evaluate the Increased Offer and announce its formal opinion on it in due course.
As previously announced, the Board of Directors of Capio is in the process of positioning Capio on its less capital intensive Nordic operations by divesting its non-Nordic businesses. An important step in this process was the announcement, August 21, 2018 of the proposed sale of Capio France to Vivalto Santé.
PJT Partners has been retained as financial adviser, Mannheimer Swartling has been retained as legal adviser, and Fogel & Partners has been retained as communication adviser to the Board of Directors of Capio.
Henrik Brehmer, Senior Vice President Group Communication & Public Affairs
Telephone: +46 761 11 34 14
This is information that Capio AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 10.45 (CEST) on October 8, 2018.